397P - Phase 1 study of sorafenib and eribulin in patients with advanced, metastatic or refractory solid tumors
| Autor: | Marmé, F., Gomez-Roca, C., Graudenz, K., Huang, F., Lettieri, J., Pena, C., Trnkova, Z., Eucker, J. |
|---|---|
| Zdroj: | In Annals of Oncology 1 October 2016 27 Supplement 6:vi127-vi127 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|